KLOW (50/10/10/10)

$150.00

This is a 4-in-1 single vial (GLOW + KPV)

  • GLOW = GHK-Cu 50mg + BPC157 10mg + TB500 10mg
  • KPV = KPV 10mg

KLOW is primarily researched for its potential to enhance tissue repair, promote skin rejuvenation, and reduce inflammation. This peptide blend combines GHK-Cu, BPC-157, TB-500, and KPV, each known for their roles in supporting cellular regeneration, collagen production, and immune modulation.

9 in stock (can be backordered)

🧬 KLOW – Research Overview

0. Category:
Healing & Recovery, Skin & Aesthetic, Anti-Aging / Longevity, Inflammation Control


1. Primary Research Use:
KLOW is primarily researched for its potential to enhance tissue repair, promote skin rejuvenation, and reduce inflammation. This peptide blend combines GHK-Cu, BPC-157, TB-500, and KPV, each known for their roles in supporting cellular regeneration, collagen production, and immune modulation.


2. Simple Analogy:
Think of KLOW as a comprehensive renovation team for the body: GHK-Cu acts as the interior designer enhancing skin aesthetics, BPC-157 serves as the repair specialist fixing internal damages, TB-500 functions as the project manager coordinating overall recovery, and KPV works as the security guard reducing unwanted inflammation.


3. What It Is (Chemical Summary):
KLOW is a peptide blend consisting of:

  • GHK-Cu (50mg): A tripeptide that binds copper, known for stimulating collagen production and skin remodeling.
  • BPC-157 (13mg): A pentadecapeptide derived from human gastric juice, recognized for promoting tissue healing and reducing inflammation.
  • TB-500 (13mg): A synthetic peptide fragment of thymosin beta-4, involved in cell migration and tissue regeneration.
  • KPV (10mg): A tripeptide with anti-inflammatory properties, studied for its role in modulating immune responses.

This combination is designed to synergistically support skin rejuvenation, tissue repair, and inflammation control.


4. Best Suited For:
This peptide blend is commonly researched by those interested in dermatological health, wound healing, anti-aging therapies, and inflammatory condition studies. It may appeal to researchers focusing on comprehensive regenerative treatments.


5. Not Recommended For / Caution In Research With:
Caution is advised when researching KLOW in individuals with:

  • Active cancer (due to potential effects on cell proliferation)
  • Pregnancy or breastfeeding (due to unknown developmental effects)
  • Copper metabolism disorders (as GHK-Cu contains copper)

6. Synergistic Peptide Stacks:

  • Epithalon: May complement KLOW by promoting telomere elongation and cellular longevity.
  • Thymosin Alpha-1: Could enhance immune modulation alongside tissue repair.
  • IGF-1 LR3: Often studied together for potential synergistic effects on muscle growth and tissue regeneration.

7. Common Dosing Guidelines (Research Use):

Experience Level Common Dosage Range
Beginner 100–200 mcg daily
Intermediate 200–400 mcg daily
Advanced 400–600 mcg daily

Note: Dosages are based on the total peptide content. Administration is typically via subcutaneous injection.


8. Cycling Information:
Research protocols often suggest continuous administration for 4–8 weeks, followed by a 2–4 week break. This cycling aims to assess efficacy and monitor for any potential desensitization or side effects.


9. Similar Peptides & Comparison Chart:

Peptide Blend Composition (GHK-Cu / BPC-157 / TB-500 / KPV) Primary Focus Dosing Frequency Notes
KLOW 50mg / 13mg / 13mg / 10mg Comprehensive healing & anti-inflammation 1x/day Includes KPV for added immune modulation
GLOW 50mg / 10mg / 10mg / — Skin rejuvenation & healing 1x/day Balanced for aesthetic and regenerative research

10. Method of Administration:
KLOW is typically administered via subcutaneous injection, allowing for systemic absorption and targeted delivery to tissues involved in regenerative processes.


11. Regulatory Status (FDA Approval):
KLOW is not approved by the FDA for any medical or veterinary use. It is classified as an investigational compound and is available for research purposes only. It has not undergone formal clinical trials in the United States.


12. Legal Disclaimer:
All products discussed are intended for laboratory, scientific, and research purposes only. These products are not approved by the FDA for human or veterinary use and are not intended to diagnose, treat, cure, or prevent any disease. They must not be used for any form of medical application or personal use.
The information presented is for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before making decisions regarding your health.
By accessing or purchasing these materials, you affirm that you are a qualified researcher or are acting under the supervision of one. All sales are final.

Reviews

There are no reviews yet.

Be the first to review “KLOW (50/10/10/10)”

Your email address will not be published. Required fields are marked *

You may also like…